DE2400218A1 - Pharmazeutische formulierungen - Google Patents

Pharmazeutische formulierungen

Info

Publication number
DE2400218A1
DE2400218A1 DE2400218A DE2400218A DE2400218A1 DE 2400218 A1 DE2400218 A1 DE 2400218A1 DE 2400218 A DE2400218 A DE 2400218A DE 2400218 A DE2400218 A DE 2400218A DE 2400218 A1 DE2400218 A1 DE 2400218A1
Authority
DE
Germany
Prior art keywords
clear solution
sulfonamide
solution according
acid
potentiator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2400218A
Other languages
German (de)
English (en)
Inventor
John R Hazlett
Elvin A Holstius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2400218A1 publication Critical patent/DE2400218A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE2400218A 1973-01-05 1974-01-03 Pharmazeutische formulierungen Withdrawn DE2400218A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB69073A GB1469521A (en) 1973-01-05 1973-01-05 Antimicrobial preparations

Publications (1)

Publication Number Publication Date
DE2400218A1 true DE2400218A1 (de) 1974-07-18

Family

ID=9708818

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2400218A Withdrawn DE2400218A1 (de) 1973-01-05 1974-01-03 Pharmazeutische formulierungen

Country Status (31)

Country Link
JP (1) JPS5344531B2 (enrdf_load_stackoverflow)
AR (1) AR204521A1 (enrdf_load_stackoverflow)
AT (1) AT331986B (enrdf_load_stackoverflow)
AU (1) AU472758B2 (enrdf_load_stackoverflow)
BE (1) BE809378A (enrdf_load_stackoverflow)
CA (1) CA1014067A (enrdf_load_stackoverflow)
CH (4) CH616930A5 (enrdf_load_stackoverflow)
CS (1) CS212740B2 (enrdf_load_stackoverflow)
CY (1) CY1070A (enrdf_load_stackoverflow)
DD (2) DD115120A5 (enrdf_load_stackoverflow)
DE (1) DE2400218A1 (enrdf_load_stackoverflow)
DK (1) DK138006B (enrdf_load_stackoverflow)
ES (1) ES427078A1 (enrdf_load_stackoverflow)
FI (1) FI55296C (enrdf_load_stackoverflow)
FR (1) FR2213060B1 (enrdf_load_stackoverflow)
GB (1) GB1469521A (enrdf_load_stackoverflow)
HK (1) HK44280A (enrdf_load_stackoverflow)
HU (1) HU171200B (enrdf_load_stackoverflow)
IE (1) IE38713B1 (enrdf_load_stackoverflow)
IL (1) IL43954A (enrdf_load_stackoverflow)
IN (1) IN138511B (enrdf_load_stackoverflow)
IT (1) IT8047967A0 (enrdf_load_stackoverflow)
KE (1) KE3065A (enrdf_load_stackoverflow)
MW (1) MW174A1 (enrdf_load_stackoverflow)
MY (1) MY8100146A (enrdf_load_stackoverflow)
NL (1) NL183927C (enrdf_load_stackoverflow)
NO (1) NO140578C (enrdf_load_stackoverflow)
PH (1) PH12388A (enrdf_load_stackoverflow)
SE (1) SE430847B (enrdf_load_stackoverflow)
ZA (1) ZA7461B (enrdf_load_stackoverflow)
ZM (1) ZM20173A1 (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816064A1 (de) * 1977-04-14 1978-10-19 Wellcome Found Veterinaermedizinische zubereitung zur behandlung von bakteriellen und protozoen-erkrankungen bei gefluegel
US4423043A (en) 1978-08-01 1983-12-27 Ciba-Geigy Corporation Aqueous liquid formulations for control of bacterial and protozoal diseases
US4532245A (en) * 1980-03-25 1985-07-30 Hoffmann-La Roche Inc. Pharmaceutical compositions
EP0653210A1 (de) 1993-09-14 1995-05-17 Hafslund Nycomed Pharma AG Intravenös verabreichbare wässrige Lösung von Sulfametrol und Trimethoprim

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
HU180740B (en) * 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
HU212498B (en) * 1992-11-06 1996-07-29 Egyt Gyogyszervegyeszeti Gyar Process for producing water-soluble pharmaceutical compositions, containing sulfachlorpyridazin-sodium and trimethoprim
WO2018229659A1 (en) 2017-06-13 2018-12-20 3M Innovative Properties Company Modified polytetrafluoroethylene and aqueous dispersion containing the same
EP3527634A1 (en) 2018-02-15 2019-08-21 3M Innovative Properties Company Fluoropolymers and fluoropolymer dispersions

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028204A (en) * 1963-06-28 1966-05-04 May & Baker Ltd Veterinary coccidiostatic compositions
DE2023977A1 (de) * 1969-05-16 1971-02-18 The Wellcome Foundation Ltd , London Verfahren zur Herstellung von Benzylpyn midinen und Zwischenprodukten
DE2152814A1 (de) * 1970-10-22 1972-05-04 Wellcome Foundation Ltd, London Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung
DE2218220A1 (de) * 1971-04-16 1972-11-02 The Wellcome Foundation Ltd., London 2.4-Diamino-5-benzylpyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
GB1405246A (en) * 1971-08-05 1975-09-10 Wellcome Found Potentiated antimicrobial compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028204A (en) * 1963-06-28 1966-05-04 May & Baker Ltd Veterinary coccidiostatic compositions
DE2023977A1 (de) * 1969-05-16 1971-02-18 The Wellcome Foundation Ltd , London Verfahren zur Herstellung von Benzylpyn midinen und Zwischenprodukten
DE2152814A1 (de) * 1970-10-22 1972-05-04 Wellcome Foundation Ltd, London Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung
DE2218220A1 (de) * 1971-04-16 1972-11-02 The Wellcome Foundation Ltd., London 2.4-Diamino-5-benzylpyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
GB1405246A (en) * 1971-08-05 1975-09-10 Wellcome Found Potentiated antimicrobial compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DE-Z.: Berliner und Münchner Tierärztliche Wochenschrift, 1968, H. 17, S.340-343 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816064A1 (de) * 1977-04-14 1978-10-19 Wellcome Found Veterinaermedizinische zubereitung zur behandlung von bakteriellen und protozoen-erkrankungen bei gefluegel
US4423043A (en) 1978-08-01 1983-12-27 Ciba-Geigy Corporation Aqueous liquid formulations for control of bacterial and protozoal diseases
US4532245A (en) * 1980-03-25 1985-07-30 Hoffmann-La Roche Inc. Pharmaceutical compositions
EP0653210A1 (de) 1993-09-14 1995-05-17 Hafslund Nycomed Pharma AG Intravenös verabreichbare wässrige Lösung von Sulfametrol und Trimethoprim

Also Published As

Publication number Publication date
BE809378A (fr) 1974-07-03
JPS49100215A (enrdf_load_stackoverflow) 1974-09-21
FR2213060B1 (enrdf_load_stackoverflow) 1976-09-03
GB1469521A (en) 1977-04-06
NO140578C (no) 1979-10-03
PH12388A (en) 1979-01-29
FR2213060A1 (enrdf_load_stackoverflow) 1974-08-02
NL183927C (nl) 1989-03-01
ATA2274A (de) 1975-12-15
MW174A1 (en) 1975-08-13
HU171200B (hu) 1977-11-28
DK138006C (enrdf_load_stackoverflow) 1979-01-08
IL43954A (en) 1977-05-31
AR204521A1 (es) 1976-02-12
DD115120A5 (enrdf_load_stackoverflow) 1975-09-12
CY1070A (en) 1980-10-24
ZA7461B (en) 1975-08-27
ZM20173A1 (en) 1974-09-23
NL183927B (nl) 1988-10-03
NL7400094A (enrdf_load_stackoverflow) 1974-07-09
CH616932A5 (en) 1980-04-30
FI55296C (fi) 1979-07-10
MY8100146A (en) 1981-12-31
AT331986B (de) 1976-09-10
ES427078A1 (es) 1976-07-16
NO140578B (no) 1979-06-25
IT8047967A0 (it) 1980-02-21
NO740022L (no) 1974-07-08
HK44280A (en) 1980-08-22
CS212740B2 (en) 1982-03-26
CH616930A5 (en) 1980-04-30
CH628335A5 (en) 1982-02-26
CA1014067A (en) 1977-07-19
SE430847B (sv) 1983-12-19
DD111156A5 (enrdf_load_stackoverflow) 1975-02-05
FI55296B (fi) 1979-03-30
IE38713L (en) 1975-07-03
IN138511B (enrdf_load_stackoverflow) 1976-02-14
AU472758B2 (en) 1976-06-03
IL43954A0 (en) 1974-05-16
IE38713B1 (en) 1978-05-24
AU6413674A (en) 1975-07-03
JPS5344531B2 (enrdf_load_stackoverflow) 1978-11-29
DK138006B (da) 1978-06-26
KE3065A (en) 1980-07-25
CH616931A5 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
DE69305642T2 (de) Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
DE2120495C2 (de) 2-Methyl-2-hydroxypropyl-4-(4-amino-6,7,8-trimethoxychinazolin-2-yl)-1-piperazincarboxylat
DE69104724T2 (de) Florfenicol enthaltendes arzneimittel.
DE3217315C2 (de) Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
US3985876A (en) Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
DE60022789T2 (de) Zusammensetzung die substituierte benzimidazole enthält
DE2400218A1 (de) Pharmazeutische formulierungen
EP0253226A1 (de) Spritzfertige, wässrige, alkalische Injektionslösung von Torasemid und Verfahren zu ihrer Herstellung
EP0007591B1 (de) Stabile flüssige Arzneimittelformulierung auf Basis von 2,6-Diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidin(Trimethoprim) und einem Sulfonamid, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69808793T2 (de) Pharmazeutische zusammensetzungen aus dalfopristine und quinupristine und verfahren zu ihrer herstellung
DE1963317A1 (de) Chemische Verfahren und Produkte
DE69232852T2 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
DE2627706C2 (de) Verfahren zur Herstellung von neutralen beständigen, mit Wasser zu klaren Lösungen verdünnbaren Sulfonamid-Potentiatorlösungen
EP0009559B1 (de) Stabile flüssige Arzneimittelformulierung, ihre Herstellung und Verwendung
DE69231098T2 (de) Lyophilisierte zusammensetzung, die s(+)-4,4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion)enthält
DE2102889C3 (de) Verwendung von SuIf adimidin und Pyrimethamin
DE3321772A1 (de) Pyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2538678A1 (de) Injizierbare loesungen
DE2445400A1 (de) Injizierbare therapeutische zubereitungen
EP1458389B1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion
DE2445401A1 (de) Injizierbare nicht-waessrige therapeutische zubereitungen
DE2112049C (de) Injizierbare Sulfonamidzubereitung
DE60107804T2 (de) Stabile pharmazeutische Nimesulidverbindungen
DE69814092T2 (de) Wassermischbare Arzneizusammensetzung von Nimesulide
DE2124937C (de) Medikament zur percutanen Behandlung von lokalen Ödemen

Legal Events

Date Code Title Description
OD Request for examination
8126 Change of the secondary classification

Free format text: A61K 31/505 A61K 31/18

8181 Inventor (new situation)

Free format text: HAZLETT, JOHN R. HOLSTIUS, ELVIN A., GREENVILLE, N.C., US

8130 Withdrawal